- Home
- PRTA vs KREF Comparison
PRTA vs KREF Comparison
Compare PRTA & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- KREF
- Stock Information
- Founded
- PRTA 2012
- KREF 2014
- Country
- PRTA Ireland
- KREF United States
- Employees
- PRTA N/A
- KREF N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- KREF Real Estate Investment Trusts
- Sector
- PRTA Health Care
- KREF Real Estate
- Exchange
- PRTA Nasdaq
- KREF Nasdaq
- Market Cap
- PRTA 809.8M
- KREF 762.7M
- IPO Year
- PRTA N/A
- KREF 2017
- Fundamental
- Price
- PRTA $12.14
- KREF $10.60
- Analyst Decision
- PRTA Buy
- KREF Buy
- Analyst Count
- PRTA 9
- KREF 7
- Target Price
- PRTA $54.57
- KREF $12.54
- AVG Volume (30 Days)
- PRTA 454.8K
- KREF 469.1K
- Earning Date
- PRTA 05-07-2025
- KREF 04-22-2025
- Dividend Yield
- PRTA N/A
- KREF 9.47%
- EPS Growth
- PRTA N/A
- KREF N/A
- EPS
- PRTA N/A
- KREF 0.19
- Revenue
- PRTA $135,157,000.00
- KREF $100,618,000.00
- Revenue This Year
- PRTA N/A
- KREF $43.93
- Revenue Next Year
- PRTA $131.75
- KREF $3.20
- P/E Ratio
- PRTA N/A
- KREF $56.07
- Revenue Growth
- PRTA 47.92
- KREF 263.33
- 52 Week Low
- PRTA $11.42
- KREF $8.71
- 52 Week High
- PRTA $25.42
- KREF $12.95
- Technical
- Relative Strength Index (RSI)
- PRTA 38.46
- KREF 37.32
- Support Level
- PRTA $11.42
- KREF $10.56
- Resistance Level
- PRTA $13.52
- KREF $10.89
- Average True Range (ATR)
- PRTA 0.75
- KREF 0.21
- MACD
- PRTA -0.12
- KREF -0.07
- Stochastic Oscillator
- PRTA 24.66
- KREF 12.62
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About KREF KKR Real Estate Finance Trust Inc.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.